UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000018757 |
|---|---|
| Receipt number | R000021700 |
| Scientific Title | A study on the blood concentration of carnosine after ingestion of carnosine in human |
| Date of disclosure of the study information | 2015/08/25 |
| Last modified on | 2016/01/07 09:34:49 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
A study on the blood concentration of carnosine after ingestion of carnosine in human
Acronym
A study on the blood concentration of carnosine after ingestion of carnosine in human
Scientific Title
A study on the blood concentration of carnosine after ingestion of carnosine in human
Scientific Title:Acronym
A study on the blood concentration of carnosine after ingestion of carnosine in human
Region
| Japan |
Condition
Condition
Not applicable
Classification by specialty
| Not applicable | Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To confirm the effect of plant-derived components on the blood concentration of carnosine after ingestion of carnosine. To confirm the safety of oral intake of plant-derived components.
Basic objectives2
Pharmacokinetics
Basic objectives -Others
Trial characteristics_1
Exploratory
Trial characteristics_2
Pragmatic
Developmental phase
Not applicable
Assessment
Primary outcomes
Efficacy : Area under the curve of blood carnosine level after ingestion of carnosine
Safety : Adverse effects
Key secondary outcomes
Efficacy : Blood carnosine level at each blood sampling time after ingestion of carnosine
Safety : Adverse events
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Self control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Prevention
Type of intervention
| Food |
Interventions/Control_1
Day0, 1 day oral intake of 900mg of Carnosine.
Day1-6, Oral intake of 1g of plant-derived components everyday.
Day7, 1day oral intake of 900mg of Carnosine & 1g of plant-derived components.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 60 | years-old | > |
Gender
Male and Female
Key inclusion criteria
1)Healthy males and females aged 20 to less than 60 years old.
2)Subjects who can make self-judgment and are voluntarily giving written informed consent.
Key exclusion criteria
1)Subjects who take continuous medical treatment.
2)Subjects who are contracting with diabetic nephropathy
3)Subjects who constantly use supplements and/or functional foods (including Food for Specified Health Uses) affecting the test results.
4)Subjects who have contracted or are contracting heart disease, liver disease, kidney disease and digestive disease.
5)Subjects who have contracted with cancer
6)Subjects who are pregnant or have possibility to bocome pregnant or planning to become pregnant during the study or breast-feeding woman.
7)Subjects who drink alcohol a lot
8)Subjects who have an extremely irregular diet habit or alternative work schedule or work on midnight shift
9)Subjects who have allergic reaction to drug medicine and food.
10)Subjects who have systolic blood pressure less than 90 mmHg.
11)Subjects who donated 200 mL of blood and/or blood components within the last one month prior to the current study.
12)Male subjects who donated 400 mL of blood within the last three months prior to the current study.
13)Female subjects who donated 400 mL of blood within the last four months prior to the current study.
14)Male subjects whose blood was collected more than 1200 mL within the last twelve months when the amount of blood sampling in the current study is added.
15)Female subjects whose blood was collected more than 800 mL within the last twelve months when the amount of blood sampling in the current study is added.
16)Subjects who are participating in other clinical studies for drug medicine or food, or who finished clinical study within four weeks, or who are planning to participate in other clinical study.
17)Subjects who are judged as unsuitable for the study by the principal investigator for other reasons.
Target sample size
10
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Junichi Nakamura |
Organization
Suntory Global Innovation Center Ltd.
Division name
Research Institute
Zip code
Address
8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto 619-0284, Japan
TEL
050-3182-0460
Junichi_Nakamura@suntory.co.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Hiroshi Watanabe |
Organization
Suntory Global Innovation Center Ltd.
Division name
Innovation Development Department
Zip code
Address
8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto 619-0284, Japan
TEL
050-3182-0593
Homepage URL
H_Watanabe@suntory.co.jp
Sponsor or person
Institute
Suntory Global Innovation Center Ltd.
Institute
Department
Personal name
Funding Source
Organization
Suntory Global Innovation Center Ltd.
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Japan
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
チヨダパラメディカルケアクリニック（東京都）
Other administrative information
Date of disclosure of the study information
| 2015 | Year | 08 | Month | 25 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2015 | Year | 08 | Month | 18 | Day |
Date of IRB
Anticipated trial start date
| 2015 | Year | 09 | Month | 01 | Day |
Last follow-up date
| 2015 | Year | 09 | Month | 15 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2015 | Year | 08 | Month | 21 | Day |
Last modified on
| 2016 | Year | 01 | Month | 07 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021700
